Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;1(3):104-5.

Outcomes research and drug development

Sandeep Duttagupta  1
Affiliations

Outcomes research and drug development

Sandeep Duttagupta. Perspect Clin Res. 2010 Jul.

Abstract

With increasing health care cost, focus needs to be given towards value-for-money, especially in the context of innovative drugs. A multi-disciplinary approach towards drug development is important in order to demonstrate the value of innovation to physicians and patients. Input into the drug development process at various stages of clinical trials must incorporate patient-focused endpoints and analyses. Demonstrating value of drugs will help ensure that innovative therapies should be seen as health care investment and not expense.

Keywords: Burden of illness; Drug development; Outcomes research; Pharmacoeconomics.

PubMed Disclaimer

References

    1. Spilker B, editor. 2nd ed. Lippincott-Raven Publishers; 1996. Quality of Life and Pharmacoeconomics in Clinical Trials.
    1. Walley T, Haycox A, Boland A. 1st ed. Churchill Livingstone: 2004. Pharmacoeconomics.
    1. Drummond MF, O’Brien B, Stoddart GL, Torrance GW. 2nd ed. Oxford Medical Publications; 1997. Methods for the Economic Evaluation of Health Care Programmes.
    1. Berger ML, Bingefors K, Hedblom EC, Pashos CL, Torrance GW. 1st ed. ISPOR Book of Terms; 2003. Health Care Cost, Quality, and Outcomes.
    1. Freemantle N, Hill S. 1st ed. BMJ Books, Blackwell Publishing; 2004. Evaluating Pharmaceuticals for Health Policy and Reimbursement.